Action Observation and Motor Imagery Therapy in Stroke

Launched by KARAMANOĞLU MEHMETBEY UNIVERSITY · Dec 4, 2023

Keywords

ClinConnect Summary

This clinical trial is studying two therapy methods called action observation (AO) and motor imagery (MI) to see if they can help people recover from a stroke. These therapies involve watching or imagining moving your body to help improve movement skills. The goal is to find out if adding AO and MI to regular rehabilitation programs can lead to better motor recovery, help with daily activities, and improve overall quality of life for stroke patients.

To participate in this trial, you must have had a stroke within the last year and be able to walk with some assistance (scores 2-5 on a specific scale). Unfortunately, those with multiple strokes, certain cognitive or severe sensory issues, or other serious health conditions may not be eligible. If you join the trial, you can expect to receive these new therapy techniques along with standard care, which could help you regain movement and independence. This study is currently recruiting participants, so it’s a chance to contribute to research that may benefit many stroke survivors in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who had a stroke in the last year
• • Functional Ambulation Classification score 2-5
• Exclusion Criteria:
• • Patients who have had repeated strokes
• • Patients with neglect
• • Patients with cognitive dysfunction (those who cannot follow simple verbal instructions)
• • Patients with severe hearing problems
• • Patients with severe vision problems
• • Patients with additional musculoskeletal system pathology that will affect physical performance (such as amputation, severe joint mobility limitation, peripheral nerve damage)
• • Patients with uncontrolled hypertension and diabetes mellitus
• • Patients with a history of symptomatic lung disease (such as asthma, chronic obstructive pulmonary disease, emphysema)
• • Patients with a history of symptomatic cardiac disease (such as coronary artery disease, arrhythmia, heart failure)
• • Patients with peripheral artery disease